Randomized, Double-Blinded, Placebo-controlled Multicenter Adaptive Phase 1-2 Trial of GC 4419, a Dismutase Mimetic, in Combination with High Dose Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (PC)
Overview
Authors
Affiliations
Zaher A, Mapuskar K, Petronek M, Tanas M, Isaacson A, Dodd R Antioxidants (Basel). 2024; 13(5.
PMID: 38790692 PMC: 11117842. DOI: 10.3390/antiox13050587.
Advances in Radiation Oncology for Pancreatic Cancer: An Updated Review.
Liu J, Lee P, McGee H, Chung V, Melstrom L, Singh G Cancers (Basel). 2022; 14(23).
PMID: 36497207 PMC: 9736314. DOI: 10.3390/cancers14235725.
Bryant J, Palm R, Liveringhouse C, Boyer E, Hodul P, Malafa M Adv Radiat Oncol. 2022; 7(6):101045.
PMID: 36420193 PMC: 9677195. DOI: 10.1016/j.adro.2022.101045.
Contemporary use and outcomes of radiation and chemotherapy for unresectable pancreatic cancer.
Moningi S, Lei X, Fang P, Taniguchi C, Holliday E, Koay E Clin Transl Radiat Oncol. 2022; 35:9-16.
PMID: 35510142 PMC: 9058953. DOI: 10.1016/j.ctro.2022.04.007.
Ablative Radiotherapy (ART) for Locally Advanced Pancreatic Cancer (LAPC): Toward a New Paradigm?.
Simoni N, Rossi G, Cellini F, Vitolo V, Orlandi E, Valentini V Life (Basel). 2022; 12(4).
PMID: 35454956 PMC: 9025325. DOI: 10.3390/life12040465.